Cargando…
A rationale to prioritise vaccination of HSCT patients against COVID-19
Autores principales: | Leclerc, Mathieu, Maury, Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816888/ https://www.ncbi.nlm.nih.gov/pubmed/33482112 http://dx.doi.org/10.1016/S2352-3026(21)00008-9 |
Ejemplares similares
-
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCT
por: Leclerc, Mathieu, et al.
Publicado: (2022) -
Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
por: Redjoul, Rabah, et al.
Publicado: (2021) -
Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022) -
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021) -
The need to prioritise childhood tuberculosis case detection
por: Nkereuwem, Esin, et al.
Publicado: (2021)